Log in
Radiology · Chest Radiology

Dilated cardiomyopathy

Dilated Cardiomyopathy

Dilated cardiomyopathy (DCM) is a myocardial pathology characterized by marked enlargement (dilation) of the left ventricular and atrial cavities. Magnetic resonance imaging plays a key role in determining the cause and prognosis of the disease, allowing differentiation between ischemic and non-ischemic etiologies.

EchocardiographyThe primary imaging method for LV dilation, but with low specificity.
Cardiac MRIA high-precision method to choose between conservative management and surgery.
Thrombus evaluationContrast-enhanced MRI outperforms echocardiography in detecting apical thrombosis.
T1 mappingAllows detection of interstitial myocardial fibrosis at the earliest stages.
5 min readFor medical studentsUpdated Sep 25, 2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Basic Methods: Chest X-ray and Echocardiography

On chest radiographs (PA and lateral views), dilated cardiomyopathy manifests as generalized cardiomegaly. Specific radiological signs include marked enlargement of the left atrium (left atrial enlargement) and left ventricle.

Echocardiography (EchoCG) is most commonly used in routine clinical practice. The main diagnostic feature on the echocardiogram is pronounced left ventricular dilation. However, the method has low specificity, making differential diagnosis challenging. In cases where echocardiography is hindered by a poor acoustic window, cardiac computed tomography (CT) can serve as an alternative for ventricular assessment.

MRI and Differential Diagnosis

Measurements obtained via MRI are exceptionally accurate and highly reproducible. The main advantage of MRI is its ability to differentiate between ischemic and non-ischemic cardiomyopathy using late gadolinium enhancement (late gadolinium enhancement, LGE).

  • Ischemic DCM: Cine-MRI (cine-MRI) shows a dilated LV with myocardial thinning (often in the inferoapical region). Contrast administration reveals subendocardial or transmural post-infarction scars (e.g., in the right coronary artery territory).
  • Non-ischemic DCM: Delayed contrast enhancement is absent or faint. When present, it is confined to the mid-myocardial layers and has a diffuse or septal pattern. Such an intramural pattern is more common in the post-myocarditic form. However, histology remains mandatory for definitive confirmation of a non-ischemic etiology.
Test your knowledge on the topicTasks from the "Diagnostic Radiology" course bank — instant answers and explanations.

T1 Mapping and ECV Assessment

The progression of DCM is associated with the development of diffuse myocardial fibrosis. Modern MRI techniques are used to detect it:

  1. Native T1 time (Native T1): In DCM, values are elevated and inversely correlate with wall thickness. Importantly, T1 increases not only in LGE regions but also in areas without visible scars, enabling early fibrosis detection.
  2. Extracellular volume (Extracellular volume, ECV): Reflects myocardial collagen content. ECV values are diffusely elevated, correlate with LV dysfunction, and serve as a non-invasive biomarker of therapeutic response. ECV values may overlap with those in hypertrophic cardiomyopathy (HCM), but these conditions are easily distinguished by ventricular morphology.

Complications and Prognostic Role

One of the frequent complications of DCM is left ventricular thrombosis. Contrast-enhanced MRI demonstrates the highest sensitivity here, detecting thrombi in areas where echocardiography often yields false-negative results (e.g., near the apex).

MRI is also in high demand prior to cardiac resynchronisation therapy (resynchronisation therapy) to assess the presence of scar tissue in the inferior LV wall. The prognostic role of DCM MRI is under active investigation: the presence and volume of late enhancement zones are associated with LV remodeling, ventricular tachycardia, and the risk of sudden cardiac death (sudden cardiac death).

Briefly: answers to topical questions

What are the etiological forms of non-ischemic dilated cardiomyopathy?

Etiological forms of non-ischemic dilated cardiomyopathy are divided into familial and non-familial.

  • Familial forms are caused by mutations in genes encoding cytoskeletal, sarcomeric, and other proteins (most commonly autosomal dominant inheritance) or are X-linked.
  • Non-familial forms (Nonfamilial DCM) include the following conditions:
  • Myocarditis (Myocarditis) — infectious and non-infectious inflammatory diseases.
  • Kawasaki disease (Kawasaki disease).
  • Eosinophilic conditions (Eosinophilic).
  • Viral persistence (Viral persistence).
  • Drugs / Toxins (Drugs).
  • Pregnancy (Pregnancy).
  • Endocrine disorders (Endocrine).
  • Nutritional deficiencies (Nutritional) — nutritional deficiency.
  • Alcoholic cardiomyopathy (Alcoholic).
  • Tachycardiomyopathy (Tachycardiomyopathy).

What ECG changes are characteristic of dilated cardiomyopathy?

Electrocardiography neither confirms nor excludes the diagnosis of dilated cardiomyopathy, but it reveals a number of associated abnormalities. The following ECG changes are characteristic of this condition:

  • Cardiac rhythm disturbances — various arrhythmias.
  • Conduction disturbances — sinoatrial, atrioventricular, and bundle branch blocks.
  • QRS complex changes — abnormal morphology and increased duration.
  • Signs of myocardial hypertrophy — increased muscle mass.
  • Ventricular overload — signs of systolic or diastolic overload.
  • Myocardial ischemia — ischemic changes.

What parameters are assessed on MRI prior to cardiac resynchronisation therapy in DCM?

Prior to cardiac resynchronisation therapy (resynchronisation therapy) in dilated cardiomyopathy, MRI is used to assess myocardial scar parameters.

  • Presence of scar tissue (scar tissue) — especially in the inferior wall of the left ventricle.
  • Extent of scarring — quantitative assessment of the lesion volume.
  • Scar heterogeneity — structure and distribution of fibrosis.
  • Scar localization — critically important for selecting the lead implantation site, as placement in a zone of necrosis or fibrosis reduces the clinical efficacy of the therapy.

How do late gadolinium enhancement patterns differ between dilated and hypertrophic cardiomyopathies?

Late gadolinium enhancement (Late gadolinium enhancement, LGE) patterns in these conditions differ significantly in severity and localization.

SignDilated cardiomyopathyHypertrophic cardiomyopathy (HCM)
SeverityAbsent or faintExtensive contrast uptake (heavy fibrosis burden)
LocalizationConfined to mid-myocardial layers (diffuse or septal pattern)Intramural hyperintense foci, predominantly in the interventricular septum
Subendocardial layerNot specifiedRelatively spared
How to memorize

Ischemic DCM = subendocardial or transmural scars (matching coronary distribution). Non-ischemic DCM = no enhancement or mid-myocardial (intramural) uptake.

Class and exam questions

Why is MRI preferred over echocardiography in DCM?

Echocardiography detects dilation but has low specificity. MRI provides accurate, reproducible measurements and visualizes scars, which is critical for determining the ischemic or non-ischemic nature of the disease and guiding treatment strategy.

What does an elevated ECV parameter mean in dilated cardiomyopathy?

Elevated ECV (extracellular volume) reflects collagen accumulation and diffuse interstitial myocardial fibrosis. This condition directly correlates with the degree of left ventricular dysfunction.

Does MRI always allow avoiding a biopsy in non-ischemic DCM?

No. Although the delayed contrast enhancement technique significantly narrows the diagnostic search, histological examination for precise verification of non-ischemic forms remains mandatory.

Didn't catch something? Ask the AIThe AI tutor has reviewed the material on "Dilated Cardiomyopathy" and will explain it in simple terms.

What else to study on this topic

  • Enhancement patterns in Fabry disease, amyloidosis, and sarcoidosis
  • Differential diagnosis of end-stage hypertrophic cardiomyopathy
  • Assessment of scar tissue prior to cardiac resynchronization therapy device implantation
  • Physics of T1 mapping and black-blood techniques in cardiac MRI

Master the entire topic in the "Diagnostic Radiology" course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Dilated Cardiomyopathy" and 2,199 other subjects
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 10 video lessons on the subject

Other topics in the «Chest Radiology» section

The entire «Chest Radiology» section

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.